{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:44:36Z","timestamp":1793105076877,"version":"4.5.0"},"reference-count":50,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:sec>\n<jats:title>OBJECT<\/jats:title>\n<jats:p>Irreversible electroporation (IRE) is a novel nonthermal ablation technique that has been used for the treatment of solid cancers. However, it has not been evaluated for use in brain tumors. Here, the authors report on the safety and feasibility of using the NanoKnife IRE system for the treatment of spontaneous intracranial gliomas in dogs.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>Client-owned dogs with a telencephalic glioma shown on MRI were eligible. Dog-specific treatment plans were generated by using MRI-based tissue segmentation, volumetric meshing, and finite element modeling. After biopsy confirmation of glioma, IRE treatment was delivered stereotactically with the NanoKnife system using pulse parameters and electrode configurations derived from therapeutic plans. The primary end point was an evaluation of safety over the 14 days immediately after treatment. Follow-up was continued for 12 months or until death with serial physical, neurological, laboratory, and MRI examinations.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Seven dogs with glioma were treated. The mean age of the dogs was 9.3 \u00b1 1.6 years, and the mean pretreatment tumor volume was 1.9 \u00b1 1.4 cm<jats:sup>3<\/jats:sup>. The median preoperative Karnofsky Performance Scale score was 70 (range 30\u201375). Severe posttreatment toxicity was observed in 2 of the 7 dogs; one developed fatal (Grade 5) aspiration pneumonia, and the other developed treatment-associated cerebral edema, which resulted in transient neurological deterioration. Results of posttreatment diagnostic imaging, tumor biopsies, and neurological examinations indicated that tumor ablation was achieved without significant direct neurotoxicity in 6 of the 7 dogs. The median 14-day post-IRE Karnofsky Performance Scale score of the 6 dogs that survived to discharge was 80 (range 60\u201390), and this score was improved over the pretreatment value in every case. Objective tumor responses were seen in 4 (80%) of 5 dogs with quantifiable target lesions. The median survival was 119 days (range 1 to &gt; 940 days).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSION<\/jats:title>\n<jats:p>With the incorporation of additional therapeutic planning procedures, the NanoKnife system is a novel technology capable of controlled IRE ablation of telencephalic gliomas.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2014.12.jns141768","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T15:46:04Z","timestamp":1435938364000},"page":"1008-1025","source":"Crossref","is-referenced-by-count":80,"title":["Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas"],"prefix":"10.3171","volume":"123","author":[{"given":"John H.","family":"Rossmeisl","sequence":"first","affiliation":[{"name":"Department of Small Animal Clinical Sciences and"},{"name":"Veterinary and Comparative Neurooncology Laboratory, Virginia-Maryland Regional College of Veterinary Medicine, and"},{"name":"Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Virginia Tech, Blacksburg, Virginia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo A.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Veterinary and Comparative Neurooncology Laboratory, Virginia-Maryland Regional College of Veterinary Medicine, and"},{"name":"Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Virginia Tech, Blacksburg, Virginia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa E.","family":"Pancotto","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Robertson","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences and"},{"name":"Veterinary and Comparative Neurooncology Laboratory, Virginia-Maryland Regional College of Veterinary Medicine, and"},{"name":"Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Virginia Tech, Blacksburg, Virginia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Henao-Guerrero","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Neal","sequence":"additional","affiliation":[{"name":"Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Virginia Tech, Blacksburg, Virginia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Ellis","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Deep Brain Stimulation Program, School of Medicine, Wake Forest University, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael V.","family":"Davalos","sequence":"additional","affiliation":[{"name":"Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Virginia Tech, Blacksburg, Virginia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns141768","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-11-0451","article-title":"Preclinical validation of electrochemotherapy as an effective treatment for brain tumors","volume":"71","author":"Agerholm-Larsen","year":"2011"},{"key":"b2-jns141768","series-title":"PLoS ONE","doi-asserted-by":"publisher","first-page":"e1135","DOI":"10.1371\/journal.pone.0001135","article-title":"Tumor ablation with irreversible electroporation","volume":"2","author":"Al-Sakere","year":"2007"},{"key":"b3-jns141768","series-title":"J Am Vet Med Assoc","first-page":"818","article-title":"Clinical signs associated with brain tumors in dogs: 97 cases (1992\u20131997)","volume":"215","author":"Bagley","year":"1999"},{"key":"b4-jns141768","series-title":"Cells","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/cells2010136","article-title":"Induction of cell death mechanisms and apoptosis by nanosecond pulsed electric fields (nsPEFs)","volume":"2","author":"Beebe","year":"2013"},{"key":"b5-jns141768","series-title":"J Surg Oncol","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/jso.23280","article-title":"Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures","volume":"107","author":"Cannon","year":"2013"},{"key":"b6-jns141768","series-title":"Biochim Biophys Acta","first-page":"158","article-title":"Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies","volume":"1836","author":"Chen","year":"2013"},{"key":"b7-jns141768","series-title":"Technol Cancer Res Treat","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7785\/tcrt.2012.500317","article-title":"Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes","volume":"12","author":"Cheung","year":"2013"},{"key":"b8-jns141768","series-title":"Ann Biomed Eng","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10439-005-8981-8","article-title":"Tissue ablation with irreversible electroporation","volume":"33","author":"Davalos","year":"2005"},{"key":"b9-jns141768","series-title":"PLoS ONE","doi-asserted-by":"publisher","first-page":"e77719","DOI":"10.1371\/journal.pone.0077719","article-title":"New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors","volume":"8","author":"Debinski","year":"2013"},{"key":"b10-jns141768","series-title":"AJR Am J Roentgenol","doi-asserted-by":"publisher","first-page":"W330","DOI":"10.2214\/AJR.10.4490","article-title":"Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization","volume":"196","author":"Deodhar","year":"2011"},{"key":"b11-jns141768","series-title":"Vet Comp Oncol","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1476-5829.2006.00101.x","article-title":"Expression of receptor tyrosine kinases VEGFR-1 (FLT-1), VEGFR-2 (KDR), EGFR-1, PDG-FRalpha and c-Met in canine primary brain tumours","volume":"4","author":"Dickinson","year":"2006"},{"key":"b12-jns141768","series-title":"Technol Cancer Res Treat","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/153303460700600403","article-title":"Mathematical modeling of irreversible electroporation for treatment planning","volume":"6","author":"Edd","year":"2007"},{"key":"b13-jns141768","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3171\/2010.5.JNS091448","article-title":"Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation","volume":"114","author":"Ellis","year":"2011"},{"key":"b14-jns141768","series-title":"Surgical Treatment of the Epilepsies","first-page":"609","article-title":"Outcome with respect to epileptic seizures","author":"Engel","year":"1993"},{"key":"b15-jns141768","series-title":"Vet Surg","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1053\/jvet.2001.25867","article-title":"Pneumonia after intracranial surgery in dogs","volume":"30","author":"Fransson","year":"2001"},{"key":"b16-jns141768","series-title":"Technol Cancer Res Treat","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7785\/tcrt.2012.500181","article-title":"Nonthermal irreversible electroporation (N-Tire) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient","volume":"10","author":"Garcia","year":"2011"},{"key":"b17-jns141768","series-title":"Tumors of the Central Nervous System","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-94-007-7217-5_15","article-title":"Nonthermal irreversible electroporation as a focal ablation treatment for brain cancer","volume":"12","author":"Garcia","year":"2014"},{"key":"b18-jns141768","series-title":"J Membr Biol","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00232-010-9284-z","article-title":"Intracranial nonthermal irreversible electroporation: in vivo analysis","volume":"236","author":"Garcia","year":"2010"},{"key":"b19-jns141768","series-title":"PLoS ONE","doi-asserted-by":"publisher","first-page":"e50482","DOI":"10.1371\/journal.pone.0050482","article-title":"7.0-T magnetic resonance imaging characterization of acute blood-brain-barrier disruption achieved with intracranial irreversible electroporation","volume":"7","author":"Garcia","year":"2012"},{"key":"b20-jns141768","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1939-1676.1991.tb00952.x","article-title":"Analysis of survival in a retrospective study of 86 dogs with brain tumors","volume":"5","author":"Heidner","year":"1991"},{"key":"b21-jns141768","series-title":"PLoS ONE","doi-asserted-by":"publisher","first-page":"e42817","DOI":"10.1371\/journal.pone.0042817","article-title":"MRI study on reversible and irreversible electroporation induced blood brain barrier disruption","volume":"7","author":"Hjouj","year":"2012"},{"key":"b22-jns141768","series-title":"Phys Med Biol","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1088\/0031-9155\/54\/19\/019","article-title":"In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome","volume":"54","author":"Ivorra","year":"2009"},{"key":"b23-jns141768","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1158\/0008-5472.CAN-06-3792","article-title":"Faithful companions: a proposal for neurooncology trials in pet dogs","volume":"67","author":"Kimmelman","year":"2007"},{"key":"b24-jns141768","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"10152","DOI":"10.1073\/pnas.0702916104","article-title":"Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors","volume":"104","author":"Kirson","year":"2007"},{"key":"b25-jns141768","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.2460\/javma.233.11.1748","article-title":"Etiology and clinical outcome in dogs with aspiration pneumonia: 88 cases (2004\u20132006)","volume":"233","author":"Kogan","year":"2008"},{"key":"b26-jns141768","series-title":"PLoS ONE","doi-asserted-by":"publisher","first-page":"e45737","DOI":"10.1371\/journal.pone.0045737","article-title":"Ex vivo and in silico feasibility study of monitoring electric field distribution in tissue during electroporation based treatments","volume":"7","author":"Kranjc","year":"2012"},{"key":"b27-jns141768","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1354\/vp.40-6-659","article-title":"Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs","volume":"40","author":"Lipsitz","year":"2003"},{"key":"b28-jns141768","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007"},{"key":"b29-jns141768","series-title":"J Am Coll Surg","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jamcollsurg.2012.05.021","article-title":"Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma","volume":"215","author":"Martin","year":"2012"},{"key":"b30-jns141768","series-title":"Acta Neuropathol","first-page":"3","article-title":"Intracranial pathology of the dog","volume":"1","author":"McGrath","year":"1962"},{"key":"b31-jns141768","series-title":"IEEE Trans Biomed Eng","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1109\/TBME.2012.2182994","article-title":"Experimental characterization and numerical modeling of tissue electrical conductivity during pulsed electric fields for irreversible electroporation treatment planning","volume":"59","author":"Neal","year":"2012"},{"key":"b32-jns141768","series-title":"J Vasc Interv Radiol","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.jvir.2012.09.012","article-title":"Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma","volume":"23","author":"Narayanan","year":"2012"},{"key":"b33-jns141768","series-title":"Ann Biomed Eng","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10439-013-0923-2","article-title":"In vitro and numerical support for combinatorial irreversible electroporation and electrochemotherapy glioma treatment","volume":"42","author":"Neal","year":"2014"},{"key":"b34-jns141768","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1200\/JCO.2010.33.0902","article-title":"Successful treatment of a large soft tissue sarcoma with irreversible electroporation","volume":"29","author":"Neal","year":"2011"},{"key":"b35-jns141768","series-title":"Technol Cancer Res Treat","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/153303460700600405","article-title":"Irreversible electroporation: implications for prostate ablation","volume":"6","author":"Onik","year":"2007"},{"key":"b36-jns141768","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2460\/ajvr.68.11.1239","article-title":"Expression of vascular endothelial growth factor in tumors and plasma from dogs with primary intracranial neoplasms","volume":"68","author":"Rossmeisl","year":"2007"},{"key":"b37-jns141768","series-title":"Vet Radiol Ultrasound","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/vru.12118","article-title":"Invited review\u2014neuroimaging response assessment criteria for brain tumors in veterinary patients","volume":"55","author":"Rossmeisl","year":"2014"},{"key":"b38-jns141768","series-title":"J Vet Sci","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4142\/jvs.2013.14.4.433","article-title":"Pathology of nonthermal irreversible electroporation (N-Tire)-induced ablation of the canine brain","volume":"14","author":"Rossmeisl","year":"2013"},{"key":"b39-jns141768","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2460\/javma.242.2.193","article-title":"Survival time following hospital discharge in dogs with palliatively treated primary brain tumors","volume":"242","author":"Rossmeisl","year":"2013"},{"key":"b40-jns141768","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1006\/bbrc.1993.1911","article-title":"A new brain tumour therapy combining bleomycin with in vivo electropermeabilization","volume":"194","author":"Salford","year":"1993"},{"key":"b41-jns141768","series-title":"IEEE Trans Biomed Eng","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1109\/TBME.2005.845212","article-title":"Sequential finite element model of tissue electropermeabilization","volume":"52","author":"Sel","year":"2005"},{"key":"b42-jns141768","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/A:1013873431159","article-title":"Metastatic seeding of the stereotactic biopsy tract in glioblastoma multiforme: case report and review of the literature","volume":"55","author":"Steinmetz","year":"2001"},{"key":"b43-jns141768","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1354\/vp.41-1-10","article-title":"Morphology, immunohistochemistry, and genetic alterations in dog astrocytomas","volume":"41","author":"Stoica","year":"2004"},{"key":"b44-jns141768","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1354\/vp.08-VP-0218-S-FL","article-title":"Identification of cancer stem cells in dog glioblastoma","volume":"46","author":"Stoica","year":"2009"},{"key":"b45-jns141768","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11060-009-9877-5","article-title":"\u2019Putting our heads together\u2019: insights into genomic conservation between human and canine intracranial tumors","volume":"94","author":"Thomas","year":"2009"},{"key":"b46-jns141768","series-title":"J Vasc Interv Radiol","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jvir.2010.12.014","article-title":"Investigation of the safety of irreversible electroporation in humans","volume":"22","author":"Thomson","year":"2011"},{"key":"b47-jns141768","series-title":"Arq Bra Med Vet Zootec","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1590\/S0102-09352010000500010","article-title":"Clinical utility of a life quality score in dogs with canine transmissible venereal tumor treated by vincristine chemotherapy","volume":"62","author":"Valladao","year":"2010"},{"key":"b48-jns141768","series-title":"Cancer Lett","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.canlet.2012.12.024","article-title":"Understanding high grade glioma: molecular mechanism, therapy and comprehensive management","volume":"331","author":"Wang","year":"2013"},{"key":"b49-jns141768","series-title":"Vet Radiol Ultrasound","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1740-8261.2010.01758.x","article-title":"Magnetic resonance imaging features of intracranial astrocytomas and oligodendrogliomas in dogs","volume":"52","author":"Young","year":"2011"},{"key":"b50-jns141768","series-title":"Int J Oncol","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3892\/ijo.2013.1770","article-title":"Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21, 783 patients","volume":"42","author":"Zinn","year":"2013"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/123\/4\/article-p1008.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/123\/4\/article-p1008.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/123\/4\/article-p1008.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T20:23:15Z","timestamp":1658694195000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/123\/4\/article-p1008.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":50,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2014.12.jns141768","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}